Cannabidiol (CBD): A New Treatment For Type 2 Diabetes
Tetrahydrocannabivarin (THCV) and cannabidiol (CBD) are phytochemicals related to the active ingredient found in marijuana but having no psychoactive effects. Based on the report published in the journal Diabetes Care in August 2016, both molecules are useful in the treatment of hyperglycemia in people who have been diagnosed with type 2 diabetes. Scientists from the University of Nottingham in Derby and many other British research institutes examined 62 participants with type 2 diabetes diagnosis.
Recent Comments